Qing Rao

11PUBLICATIONS
22CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 07, 2025
The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation.

Yishuang Li, Zhijie Cao, Haiyan Xing

|Apr 15, 2025
Correction: Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway.

Yingxi Xu, Junli Mou, Ying Wang

|Nov 01, 2024
The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patients.

Shaowei Qiu, Yihan Mei, Runxia Gu

|Sep 16, 2024
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia.

Yu Liu, Wenbing Liu, Anli Lai

|Sep 12, 2024
Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells.

Xiaoyu Liu, Yu Liu, Qing Rao

|Jun 26, 2024
Slow-replicating leukemia cells represent a leukemia stem cell population with high cell-surface CD74 expression.

Huan Li, Zhijie Cao, Yiming Liu

Pageof 2

Frequent Collaborators

11 joint publications

Jianxiang Wang

7 joint publications

Min Wang

4 joint publications

Yingxi Xu

3 joint publications

Shaowei Qiu